David Pernock
2010 - Fibrocell Science
In 2010, David Pernock earned a total compensation of $1.6M as Chief Executive Officer at Fibrocell Science.
Compensation breakdown
| Option Awards | $1,036,491 |
|---|---|
| Salary | $415,385 |
| Other | $104,167 |
| Total | $1,556,043 |
Pernock received $1M in option awards, accounting for 67% of the total pay in 2010.
Pernock also received $415.4K in salary and $104.2K in other compensation.
Rankings
In 2010, David Pernock's compensation ranked 3,835th out of 10,439 executives tracked by ExecPay. In other words, Pernock earned more than 63.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,835 out of 10,439 | 63rd |
Division Manufacturing | 1,344 out of 3,838 | 65th |
Major group Chemicals And Allied Products | 263 out of 921 | 71st |
Industry group Drugs | 143 out of 680 | 79th |
Industry Pharmaceutical Preparations | 110 out of 481 | 77th |
Source: SEC filing on August 6, 2012.
Pernock's colleagues
We found two more compensation records of executives who worked with David Pernock at Fibrocell Science in 2010.
News
Eagle Pharmaceuticals CEO Scott Tarriff's 2021 pay falls 32% to $6.5M
June 15, 2022
Eagle Pharmaceuticals CEO Scott Tarriff's 2020 pay rises 20% to $9.5M
April 30, 2021
Eagle Pharmaceuticals CEO Scott Tarriff's 2019 pay falls 30% to $7.9M
April 29, 2020
Eagle Pharmaceuticals CEO Scott Tarriff's 2018 pay jumps 41% to $11M
April 30, 2019